HER2/neu is the human epidermal growth factor receptor 2, also called ERBB2 (Erb-B2 receptor tyrosine kinase 2); HER2 gene encodes transmembrane growth ...

18 июн. 2021 г. · A cytoplasmic marker, overexpression of which bodes poor prognosis in untreated gastric and gastroesophageal junction (GEJ) adenocarcinomas ...

6 февр. 2024 г. · HER2 low breast cancer is defined as either HER2 IHC score of 1+ OR 2+ / ISH not amplified; it is a eterogenous group that includes hormone ...

6 мая 2024 г. · A. An equivocal result of HER2 staining in colorectal adenocarcinoma is moderate (2+) in ≥ 50% of cells in circumferential, basolateral or ...

23 янв. 2024 г. · Molecular subtypes · Lifetime risk. Luminal A and B: 6.79%; HER2 positive: 1.78%; Triple negative: 1.2% · Overall frequency. Luminal A: 30 - 40% ...

9 февр. 2022 г. · Trastuzumab · HER2 / neu signaling in cancer cells: HER2 heterodimerizes with HER1, HER3 or HER4, phosphorylates and activates intracellular ...

15 мая 2024 г. · ... HER2 breast hormone receptors Ki67 breast mammaglobin p40 p63 p120 catenin PDL1 22C3 PR SMMHC / smooth muscle myosin heavy chain SOX10 TRPS1 Fibroadenoma · Invasive ductal carcinoma · DCIS · Phyllodes tumor

15 мая 2024 г. · Learning Objectives: --Recognize the changing landscape of HER2 testing and treatment, its impact on assessing HER2 IHC status in breast cancer, ...

24 янв. 2024 г. · Good prognosis, ER / PR negative, HER2 negative. Tall cell carcinoma with reversed polarity (TCCPR) is a rare subtype of invasive breast ...

5 янв. 2024 г. · 8 likes, 0 comments - pathoutlines on January 5, 2024: "The future of HER2 diagnostics is changing with the first test to detect HER2-low ...